関連する実験動画
Updated: Sep 10, 2025

11:48
Detection of Alternative Splicing During Epithelial-Mesenchymal Transition
Published on: October 9, 2014
13.0K
ミエロディスプラスティック症候群の遺伝子情報ネットワークモデル: スプライシング異常から治療的脆弱性まで
Sanghyeon Yu1,2, Junghyun Kim3, Man S Kim1,2
1Translational-Transdisciplinary Research Center, Clinical Research Institute, Kyung Hee University Hospital at Gangdong, College of Medicine, Kyung Hee University, Seoul 05278, Republic of Korea.
Genes
|August 28, 2025
まとめ
ミエロディスプラスティック症候群 (MDS) は遺伝,幹細胞,表層伝染,および微環境要因によって引き起こされます. これらの相互に関連したメカニズムを理解することで 治療の成果を向上させるための 精密医療のアプローチが可能になります
科学分野:
- 血液学
- 遺伝学
- 腫瘍学
背景:
- ミエロディスプラスティック症候群 (MDS) は,白血病のリスクが高い複雑な血液疾患です.
- 低メチル化剤を含む現在の治療は 患者の約半分にしか効果がありません
研究 の 目的:
- MDSの病原性を理解する最近の進歩をレビューする.
- これらの発見を 精密な治療戦略に変換することを 探求すること
主な方法:
- 単細胞マルチオミクス,エピトランスクリプトミクス,幹細胞構造,精密医療の分析.
- MDSにおける細胞型特異のスプライシング,幹細胞パターン,表表表記学的変化,および微環境的要因の検討.
主要な成果:
- MDSの病原性には,遺伝的変異,異常な幹細胞構造 (CMP対GMPパターン),表表表記体調節障害,および微小環境の変化が含まれます.
- 幹細胞の構造はヴェネトクラックスへの反応を予測し,CMPパターンのMDSは有意に高い反応率を示しています.
- スプライシング異常は細胞型特異的 (例えば,赤血球系におけるSF3B1) であり,表表表記学的変異は予後的価値を提供する.
結論:
- MDSの研究の進歩は パーソナライズされた医療への パラダイムシフトをサポートしています
- MDSにおける現在の治療上の限界を克服するために,包括的な分子プロファイリングとマルチターゲットの戦略は極めて重要です.
関連する概念動画
RNA Splicing
56.9K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
56.9K
Alternative RNA Splicing
21.7K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
21.7K
Mismatch Repair
5.2K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
5.2K
Nonsense-mediated mRNA Decay
10.8K
The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
10.8K

